pathology
People, technologies and companies concerned with pathology and its digitisation. 19 records carry it: 12 technologies, 5 people, 1 front, 1 company.
Related tags
19 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Anna Sapino Scientific Director · Istituto di Candiolo IRCCS (FPO) Pathologist and Scientific Director of the Candiolo Cancer Institute (INOC), Piedmont's oncology IRCCS and an OECI-certified Comprehensive Cancer Centre. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer | none | leadership, clinician-scientist, breast cancer | ||
Atlas (Aignostics, Mayo Clinic, Charité) Atlas is a pathology foundation model trained on 1.2 million slides from two of the world's largest hospitals. | none | foundation-model | |||
CHIEF (Harvard, Yu Lab) A pathology model trained across 19 cancer types that predicts survival and mutations from slides. | none | foundation-model | |||
Diagnostics & Biomarkers Tests on tissue and blood that say what kind of cancer it is, what is driving it, and which drugs might work. | none | none | genomics, liquid-biopsy | ||
Faisal Mahmood Associate Professor of Pathology, Harvard Medical School and Brigham and Women's Hospital; Associate Member, Broad Institute · Broad Institute of MIT and Harvard Built UNI and CONCH, the pathology foundation models that let AI read whole-slide images across cancer types. | none | none | ai, foundation-models | ||
H-optimus (Bioptimus) An open 1.1-billion-parameter pathology model from a French startup, among the strongest on public benchmarks. | none | foundation-model | |||
Hibou (HistAI) Hibou is a family of open pathology foundation models under a permissive licence. | none | foundation-model | |||
Jakob Nikolas Kather Professor of Clinical Artificial Intelligence, Else Kröner Fresenius Center for Digital Health, TU Dresden; Medical Oncologist, NCT Dresden · NCT/UCC Dresden, University Hospital Carl Gustav Carus Showed that deep learning can read genetic features like microsatellite instability directly from routine pathology slides. | Colorectal cancer, Gastric & gastro-oesophageal junction cancer | none | ai, biomarkers, germany | ||
Midnight (kaiko.ai) Midnight is a pathology model that matched the leaders while training on far fewer slides. | none | foundation-model | |||
MUSK (Stanford, vision-language pathology) A model that reads slides and clinical text together to predict who will respond to immunotherapy. | Melanoma, Non-small-cell lung cancer | foundation-model | |||
Phikon / Phikon-v2 (Owkin) Owkin's open pathology models trained on TCGA and its federated hospital network. | none | foundation-model | |||
PLUTO (PathAI) PLUTO is PathAI's compact pathology foundation model, a vision transformer pretrained at several magnifications on 195 million tiles from 158,000 slides, so one network serves slide-level and biomarker quantification tasks at whatever resolution each needs. It runs inside PathAI's AISight product, but its weights are proprietary, so outside groups cannot benchmark or adapt it. | none | foundation-model | |||
Prov-GigaPath (Microsoft, Providence) An open pathology model trained on 1.3 billion image tiles from a US health system, modelling whole slides at gigapixel scale. | none | foundation-model | |||
Strand AI San Francisco, CA, US · YC W26 Strand AI's first model, Lattice, predicts which proteins sit where across a tumour from the ordinary stained slide a hospital already has, so a whole archive can be profiled without spending tissue on extra laboratory staining. | none | none | foundation-model | ||
Sunil Lakhani Chair of the Board · Breast Cancer Trials Brisbane breast pathologist who chairs the board of Breast Cancer Trials, the Australia and New Zealand breast cancer clinical trials group. | HR-positive / HER2-negative breast cancer, HER2-positive breast cancer, Triple-negative breast cancer | none | leadership, clinician-scientist, breast cancer | ||
Thomas J. Fuchs Dean of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai; Co-founder, Paige · The Mount Sinai Hospital / Tisch Cancer Institute Trained the first clinical-grade AI on tens of thousands of slides, leading to the first FDA-authorised AI pathology product. | Prostate cancer | none | ai, digital-pathology | ||
TITAN (whole-slide multimodal model) TITAN is a model that summarises a whole slide, not just tiles, and can write a draft pathology report. | none | foundation-model | |||
UNI and CONCH (Harvard, Mahmood Lab) Two open academic pathology models: UNI reads tissue images, CONCH links images with pathology text. | none | foundation-model | |||
Virchow / Virchow2 (Paige, MSK) A pathology foundation model trained on millions of slides that can detect cancer and predict biomarkers from an ordinary H&E slide. | none | foundation-model |